RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Roche Holding AG

A collection of news and information related to Roche Holding AG published by this site and its partners.

Top Roche Holding AG Articles

Displaying items 12-22
  • Achillion's hepatitis C drug shows promise in trial

    (Reuters) - Achillion Pharmaceuticals Inc said all patients treated with its experimental hepatitis C drug showed no detectable levels of the virus four weeks after the therapy, sending its shares up 18 percent. The mid-stage trial tested Achillion's...
  • Gilead says panel rejects Roche's claims on hepatitis C drug

    (Reuters) - Gilead Sciences Inc said an arbitration panel rejected Roche Holding AG's patent infringement claims related to Gilead's hepatitis C drug, Sovaldi. Gilead's shares rose as much as 3 percent in early trading. "While this outcome was widely...
  • Roche to offer $10 billion for rest of Chugai: Bloomberg

    (Reuters) - Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported, citing people familiar with the matter. A spokeswoman for Roche...
  • Healthcare: A remedy for long-term investors

    CHICAGO (Reuters) - (The opinions expressed here are those of the author, a columnist for Reuters.) For healthcare, gray is the new black. The fastest-growing segment of the global population is aged 60 and over, according to the United Nations...
  • Studies highlight treatment realities and promising new drugs

     Studies highlight treatment realities and promising new drugs
    234,000 number of Americans who will be diagnosed with breast cancer this year, according to the American Cancer Society. Men account for 2,240 cases. An estimated 40,000 will die from the disease. 55.9% of black women on Medicare who were told they...
  • Netflix still navigating troubled waters after price-hike two-step

    About Netflix Inc. Ticker: NFLX Exchange: Nasdaq What does the company do? Subscription-based Internet service and DVD rental for TV shows and movies 2010 Financial report: Net revenues: $2.16 billion Net income: $161 million Q. I am worried...
  • New cancer tools allow patients to reconsider chemo

    New cancer tools allow patients to reconsider chemo
    LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...
  • Scientists see AIDS vaccine within reach after decades

    Scientists see AIDS vaccine within reach after decades
    CHICAGO (Reuters) - At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years. But a string of failed attempts - punctuated by a...
  • New help for basal cell skin cancer patients

     
    On Monday, the U.S. Food & Drug Administration approved a new drug to treat advanced basal cell carcinoma, the most common form of skin cancer. This is good news for the approximately 2.8 million Americans who will be diagnosed with a basal-cell...
  • Seattle Genetics cancer drug price may top $100,000

    Seattle Genetics cancer drug price may top $100,000
    The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost. The U.S. Food and Drug Administration on Friday gave its nod to Adcetris, the first...
  • Vertex Hepatitis-C Drug OK'd, Promising More Cures

    Vertex Hepatitis-C Drug OK'd, Promising More Cures
    Vertex Pharmaceuticals Inc's highly anticipated hepatitis C drug won U.S. approval, promising far higher cure rates for the liver-destroying disease and setting up a head-to-head marketing battle with a rival new medicine from Merck & Co. Incivek, a pill...